Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2010 | 1 |
2012 | 2 |
2022 | 1 |
2023 | 0 |
Search Results
5
results
Results by year
Page 1
LoRa Based IoT Platform for Remote Monitoring of Large-Scale Agriculture Farms in Chile.
Sensors (Basel). 2022 Apr 7;22(8):2824. doi: 10.3390/s22082824.
Sensors (Basel). 2022.
PMID: 35458808
Free PMC article.
De novo induction of genetically engineered brain tumors in mice using plasmid DNA.
Wiesner SM, Decker SA, Larson JD, Ericson K, Forster C, Gallardo JL, Long C, Demorest ZL, Zamora EA, Low WC, SantaCruz K, Largaespada DA, Ohlfest JR.
Wiesner SM, et al. Among authors: gallardo jl.
Cancer Res. 2009 Jan 15;69(2):431-9. doi: 10.1158/0008-5472.CAN-08-1800.
Cancer Res. 2009.
PMID: 19147555
Free PMC article.
Item in Clipboard
9-Amino acridine pharmacokinetics, brain distribution, and in vitro/in vivo efficacy against malignant glioma.
Teitelbaum AM, Gallardo JL, Bedi J, Giri R, Benoit AR, Olin MR, Morizio KM, Ohlfest JR, Remmel RP, Ferguson DM.
Teitelbaum AM, et al. Among authors: gallardo jl.
Cancer Chemother Pharmacol. 2012 Jun;69(6):1519-27. doi: 10.1007/s00280-012-1855-5. Epub 2012 Mar 9.
Cancer Chemother Pharmacol. 2012.
PMID: 22402637
Item in Clipboard
Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux.
Agarwal S, Sane R, Gallardo JL, Ohlfest JR, Elmquist WF.
Agarwal S, et al. Among authors: gallardo jl.
J Pharmacol Exp Ther. 2010 Jul;334(1):147-55. doi: 10.1124/jpet.110.167601. Epub 2010 Apr 26.
J Pharmacol Exp Ther. 2010.
PMID: 20421331
Free PMC article.
Item in Clipboard
Active efflux of Dasatinib from the brain limits efficacy against murine glioblastoma: broad implications for the clinical use of molecularly targeted agents.
Agarwal S, Mittapalli RK, Zellmer DM, Gallardo JL, Donelson R, Seiler C, Decker SA, Santacruz KS, Pokorny JL, Sarkaria JN, Elmquist WF, Ohlfest JR.
Agarwal S, et al. Among authors: gallardo jl.
Mol Cancer Ther. 2012 Oct;11(10):2183-92. doi: 10.1158/1535-7163.MCT-12-0552. Epub 2012 Aug 13.
Mol Cancer Ther. 2012.
PMID: 22891038
Free PMC article.
Item in Clipboard
Cite
Cite